Abbott Laboratories
SIX:ABT
Wall Street
Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for
ABT
is 99.3131 CHF
with a low forecast of 84.8854 CHF and a high forecast of 114.8695 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABT's stock price target?
Price Target
99.3131
CHF
According to Wall Street analysts, the average 1-year price target for
ABT
is 99.3131 CHF
with a low forecast of 84.8854 CHF and a high forecast of 114.8695 CHF.
What is Abbott Laboratories's Revenue forecast?
Projected CAGR
8%
For the last 13 years the
compound annual growth rate for
Abbott Laboratories's revenue is
5%.
The projected
CAGR
for the next 3 years is
8%.
What is Abbott Laboratories's Operating Income forecast?
Projected CAGR
23%
For the last 13 years the
compound annual growth rate for
Abbott Laboratories's operating income is
12%.
The projected
CAGR
for the next 3 years is
23%.
What is Abbott Laboratories's Net Income forecast?
Projected CAGR
-6%
For the last 13 years the
compound annual growth rate for
Abbott Laboratories's net income is
8%.
The projected
CAGR
for the next 3 years is
-6%.
You don't have any saved screeners yet
